EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online November 7, 2008
Proceedings of the Society for Experimental Biology and Medicine doi: 10.3181/0806-RM-189
© 2008 by the Society for Experimental Biology and Medicine

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
234/1/112    most recent
0806-RM-189v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Nojiri, K.
Right arrow Articles by Imai, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nojiri, K.
Right arrow Articles by Imai, T.


Regular Manuscript

The proangiogenic factor Ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation

Kazunori Nojiri 1, Mayumi Iwakawa 2*, Yasushi Ichikawa 3, Kaori Imadome 2, Minako Sakai 2, Miyako Nakawatari 2, Ken-ichi Ishikawa 2, Atsuko Ishikawa 2, Shinji Togo 3, Hirohiko Tsujii 2, Hiroshi Shimada 3, and Takashi Imai 2

1 National Institute of Radiological Sciences
2 National Institute of Radiological Sciences (NIRS)
3 Yokohama City University, Graduate School of Medicine

* To whom correspondence should be addressed. E-mail: mayumii{at}nirs.go.jp.


   Abstract

While the pre-treatment status of cancer is generally correlated with outcome, little is known about microenvironmental change caused by anti-cancer treatment and how it may affect outcome. For example, treatment may lead to induction of gene expression that promotes resistance to therapy. In the present study, we attempted to find a gene that was both induced by irradiation and associated with radioresistance in tumors. Using single-color oligo-microarrays, we analyzed the gene expression profiles of two murine squamous cell carcinomas, NR-S1, which is highly radioresistant, and SCCVII, which is radiosensitive, after irradiation with 137-Cs gamma rays or carbon ions. Candidate genes were those differentially regulated between NR-S1 and SCCVII after any kind of irradiation. Four genes, Efna1 (Ephrin-A1), Sprr1a (small proline-rich protein 1A), Srgap3 (SLIT-ROBO Rho GTPase activating protein 3) and Xrra1 [RIKEN 2 days neonate thymus thymic cells (NOD) cDNA clone E430023D08 3'], were selected as candidate genes associated with radiotherapy-induced radioresistance. We focused on Efna1, which encodes a ligand for the Eph receptor tyrosine kinase known to be involved in the vascular endothelial growth factor (VEGF) pathway. We used immunohistochemical methods to detect expression of Ephrin-A1, VEGF, and the microvascular marker CD31 in radioresistant NR-S1 tumor cells. Ephrin-A1 was detected in the cytoplasm of NR-S1tumor cells after irradiation, but not in SCCVII tumor cells. Irradiation of NR-S1 tumor cells also led to significant increases in microvascular density, and up-regulation of VEGF expression. Our results suggest that radiotherapy-induced changes in gene expression related with angiogenesis might also modulate microenvironment and influence responsiveness of tumors.

Key Words: Ephrin-A1, Radioresistancy, Irradiation, Mouse tumor model, Microarray







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Experimental Biology and Medicine.